Skip to main content

ACE Tries Out Gyros New System for MALDI-Mass-Spec Sample Prep

NEW YORK, Jan.7 - Gyros AB and ACE BioSciences struck a proteomics collaboration, Gyros announced Monday. The two will work together to test Gyros' new technique for miniaturizing and automating sample preparation for protein identification.

 

The Gyros system, now in prototype form, is designed to automate sample prep for MALDI mass spectrometry and boost sensitivity in protein identification. It is a new application of the company's core platform, by which laboratory processes are miniaturized and embedded into CDs for parallel preparation and processing.

 

By the terms of the partnership, ACE BioSciences will use the Gyros product for protein identification in its functional proteomics program. The company is "positioned to give us high-quality professional feedback," said Gyros executive vice president Pej Sjoeberg in a statement.

 

Uppsala, Sweden-based Gyros was spun off from Amersham Pharmacia Biotech in 2000.

 

ACE BioSciences, a functional proteomics company based in Odense, Denmark, is building a protein interaction database of pathogens. The company uses this database to identify novel microorganism drug targets.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.